Company
Hangzhou Sciwind Biosciences Co., Ltd.
Hangzhou Sciwind Biosciences Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ecnoglutide tablet | Phase 2 | Overweight , Obesity |
Latest
No recent events.
Follow Hangzhou Sciwind Biosciences Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.